Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Appl Toxicol ; 29(8): 648-55, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19557771

ABSTRACT

A wide number of pesticides, including highly persistent organochlorinated compounds, such as lindane (LIN), may induce reproductive and developmental alterations by directly binding to the estrogen/androgen receptors or altering steroid hormone metabolism. In the present work, we have investigated whether LIN in utero exposure of CD1 mice affects the reproductive system in male offspring by causing an impairment of the CYP-dependent steroid hormone metabolism. Dam exposure to 25 mg kg(-1) b.w. LIN occurred during critical developmental periods, from gestational days 9 to 16. Effects on hepatic CYP-mediated testosterone (TST) hydroxylase, aromatase activities and testicular parameters were tested at postnatal days (PND 50, 65-69, 100) that are critical for sexual maturation in CD1 mice. In the adult F1 mice significant changes of male reproductive endpoints (testis weight, spermatid number) as well as dramatic effects on CYP-mediated TST metabolism were observed on PND 65-69, in the absence of any of systemic toxicity. The levels of TST 6beta- and 2alpha-hydroxylation and dehydrogenation showed the highest level of reduction, suggesting CYP 3A and 2C families as the major target of LIN induced effects. All changes were almost recovered on PND 100. No effects on aromatase activity were evidenced. Overall, these findings provide useful information for a better characterization of the LIN mode of action. They suggest that LIN-induced toxicity in males is linked to an impairment of steroid hormone homeostasis, due to CYP-mediated TST catabolism modulation and differs from LIN receptor-mediated mechanism previously reported in females.


Subject(s)
Cytochrome P-450 Enzyme System/metabolism , Gonadal Steroid Hormones/metabolism , Hexachlorocyclohexane/toxicity , Insecticides/toxicity , Prenatal Exposure Delayed Effects , Aging , Animals , Aromatase/metabolism , Body Weight/drug effects , Female , Liver/drug effects , Liver/enzymology , Liver/pathology , Male , Maternal Exposure/adverse effects , Mice , Microsomes, Liver/drug effects , Microsomes, Liver/enzymology , Microsomes, Liver/metabolism , Organ Size/drug effects , Pregnancy , Random Allocation , Semen Analysis , Testis/drug effects , Testis/pathology , Testosterone/metabolism
2.
Ann Ist Super Sanita ; 44(3): 281-91, 2008.
Article in English | MEDLINE | ID: mdl-18946168

ABSTRACT

The presence of persistent organic pollutants (POPs) in the fetal environment raises concerns for their possible interferences with the developmental process, resulting into morphological and/or functional impairments of the organism. Human biomonitoring has been widely recognized as the action to be undertaken to characterize children's exposure to environmental pollutants in the different life stages, starting from conception. The main objective of the present study was to analyze the relationship between concentrations assessed in maternal blood versus those present in umbilical cord blood to evaluate if POP levels determined in maternal blood can be considered representative of fetal exposure. Data on POP concentrations determined in maternal blood and umbilical cord blood were retrieved from literature. Studies selected used highly specific analytical techniques, and were published within the last 15 years. Our analysis involved POPs of high toxicological significance, as organochlorinated pesticides, polychlorodibenzodioxins and poliychlorodibenzofurans, polychlorobiphenyls and their hydroxylated metabolites, and polybromodiphenylethers. Linear correlations between maternal and cord blood concentrations, expressed on a lipid base, were observed for most of these pollutants. This result indicates a possible use of data on maternal blood POP levels to quantitatively predict in utero exposure.


Subject(s)
Environmental Pollutants/blood , Pregnancy/blood , Umbilical Cord/chemistry , Female , Humans
3.
Toxicol Appl Pharmacol ; 221(1): 95-101, 2007 May 15.
Article in English | MEDLINE | ID: mdl-17442358

ABSTRACT

The effects on the hypothalamus-pituitary-testicular axis of the well-known antispermatogenic drug lonidamine (LND) has not been elucidated so far. In the present study, the possible changes of the testicular steroid hormones were evaluated in immature mice for a better characterization of the LND adverse effects both in its use as antitumoral agent and male contraceptive. Male CD1 mice were orally treated on postnatal day 28 (PND28) with LND single doses (0 or 100 mg/kg b.w.) and euthanized every 24 h from PND29 to PND32, on PND35 and on PND42 (1 and 2 weeks after the administration, respectively). Severe testicular effects were evidenced in the LND treated groups, including: a) significant testis weight increase, 24 h and 48 h after dosing; b) sperm head counts decrease (more than 50% of the control) on PND29-32; c) damage of the tubule morphology primarily on the Sertoli cell structure and germ cell exfoliation. All these reproductive endpoints were recovered on PND42. At the same time, a significant impairment of the testicular steroid balance was observed in the treated mice, as evidenced by the decrease of testosterone (T) and androstenedione (ADIONE) and the increase of 17OH-progesterone (17OH-P4) on the first days after dosing, while the testicular content of 17beta-estradiol (E2) was unchanged. The hormonal balance was not completely restored afterwards, as levels of T, ADIONE and 17OH-P4 tended to be higher in the treated mice than in the controls, on PND35 and PND42. These data showed for the first time that LND affects intratesticular steroids in experimental animals. However further data are needed both to elucidate the mechanism responsible for the impairment of these metabolic pathways and to understand if the androgens decrease observed after LND administration could be partially involved in the testicular damage.


Subject(s)
Indazoles/toxicity , Testicular Hormones/metabolism , Testis/drug effects , Age Factors , Androstenedione/metabolism , Animals , Antispermatogenic Agents/administration & dosage , Antispermatogenic Agents/toxicity , Enzyme-Linked Immunosorbent Assay , Estradiol/metabolism , Hydroxyprogesterones/metabolism , Indazoles/administration & dosage , Intubation, Gastrointestinal , Male , Mice , Microscopy, Polarization , Organ Size/drug effects , Seminiferous Tubules/drug effects , Seminiferous Tubules/pathology , Sertoli Cells/drug effects , Sertoli Cells/pathology , Sperm Count , Spermatogenesis/drug effects , Spermatozoa/drug effects , Spermatozoa/pathology , Testis/metabolism , Testis/pathology , Testosterone/metabolism , Time Factors
4.
Contraception ; 72(4): 262-7, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16181969

ABSTRACT

Lonidamine (LND) [1-(2,4-dichlorobenzyl)-1H-indazole-3-carboxylic acid], a well-known antispermatogenic drug, was studied for the first time in pubertal mice to assess its possible effects on spermatogenesis. Male CD1 mice were orally treated on Postnatal Day (PND) 28 with a single dose of LND (100 mg/kg body weight) and sacrificed on PND30, PND42, PND74 and PND123. On PND30 (48 h after dosing), severe testicular effects were evidenced in the treated animals: (a) reduction of the testicular sperm head concentration (approximately 50% of the control value); (b) changes in the spermatogenic cell type distribution (mild decrease of the elongated spermatids and S-phase cells fractions); and (c) morphological alterations of the Sertoli cell cytoplasm and germ cell exfoliation. These changes were recovered in adulthood, on PND74 and PND123. However, no effect on sperm chromatin structure was detected on the epididymal sperm of mature mice by sperm chromatin structure assay, suggesting that LND did not interfere with the process of chromatin reorganization and DNA packaging.


Subject(s)
Antispermatogenic Agents/pharmacology , Indazoles/pharmacology , Sexual Maturation , Spermatogenesis/drug effects , Animals , Chromatin/ultrastructure , DNA/analysis , Flow Cytometry , Indazoles/toxicity , Male , Mice , Organ Size/drug effects , Sperm Count , Sperm Head , Spermatozoa/drug effects , Spermatozoa/physiology , Spermatozoa/ultrastructure , Testis/ultrastructure
5.
Reprod Toxicol ; 17(1): 25-35, 2003.
Article in English | MEDLINE | ID: mdl-12507655

ABSTRACT

Long-lasting effects on mouse spermatogenesis induced by prenatal exposure to the insecticide lindane have been investigated by conventional reproductive endpoints complemented by the flow cytometric (FCM) DNA content analysis of testis cells and by the Sperm Chromatin Structure Assay (SCSA). Two lindane dose levels, 15 and 25 mg/kg bw, and diethylstilboestrol (DES, 10 microg/kg bw) as positive control, were administered daily by gavage to pregnant CD1 mice on gestation days (GD) 9-16. Reproductive endpoints were evaluated on F1 male mice on postnatal day (PND) 60; additionally, animals treated with lindane 25 mg/kg per day and DES were examined on PND 100 to evaluate the possible reversibility of the effects. On PND 60, lindane and DES caused a reduction in the sperm head count and concentration, with recovery in older lindane 25 mg/kg per day animals (PND 100). By contrast, the DES group exhibited a greater reduction in the sperm head count on PND 100 than on PND 60. Changes in biochemical parameters in the testes, lactate dehydrogenase-C(4) (LDH-C(4)), and sorbitol dehydrogenase (SDH) activities, were also observed in adult treated F1 mice. Furthermore on PND 60, the FCM analysis revealed changes in the pattern of testicular germ cell distribution, especially in the haploid subcompartment, in the lindane 25 mg/kg per day group. A dose-dependent increase in chromatin abnormalities of the epididymal sperm was also shown by SCSA. These changes recovered on PND 100. Preliminary qualitative examination did not reveal any significant difference in the structure of testicular tissue; however, there were suggestions of a moderate increase in number and size of Leydig cells in both DES- and lindane-treated animals. The partial reversibility of these effects and the lack of structural modification of the testicular tissue as evidenced by histopathologic assessment suggest a functional impairment of sperm production and maturation, possibly associated with changes induced by lindane on factors affecting intratesticular steroidogenesis.


Subject(s)
Androgen Antagonists/toxicity , Environmental Pollutants/toxicity , Hexachlorocyclohexane/toxicity , Maternal Exposure/adverse effects , Prenatal Exposure Delayed Effects , Spermatogenesis/drug effects , Administration, Oral , Androgen Antagonists/administration & dosage , Animals , Animals, Newborn , Chromatin/chemistry , DNA/analysis , DNA Damage , Diethylstilbestrol/administration & dosage , Diethylstilbestrol/toxicity , Environmental Pollutants/administration & dosage , Female , Flow Cytometry , Hexachlorocyclohexane/administration & dosage , Infertility, Male/chemically induced , Male , Mice , Mice, Inbred Strains , Pregnancy , Spermatogenesis/physiology , Spermatozoa/drug effects , Spermatozoa/pathology , Testis/chemistry , Testis/drug effects , Testis/pathology , Toxicity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...